UK health authorities pave the way for prescription-only stronger e-cigs

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) is backing the idea of e-cigarettes as a licensed therapy, available on prescription from the National Health Service (NHS), for smokers who want to quit.

The MHRA’s updated “Guidance for licensing electronic cigarettes and other inhaled nicotine-containing products as medicines” suggests e-cigarettes may be made available for medicinal purposes in strengths and volumes greater than those currently permitted.

Read full article
I'm already a subscriber
Author default picture

David Palacios Rubio

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization